We are pleased to announce that the @US_FDA has now approved our gene therapy for the treatment of hemophilia B! #PfizerMedical Affairs For more information, click these links on.pfizer.com/3w9qSGW, on.pfizer.com/3waI8eS, and on.pfizer.com/3Whrdlv

We are pleased to announce that the @US_FDA has now approved our gene therapy for the treatment of hemophilia B! #PfizerMedical Affairs For more information, click these links on.pfizer.com/3Qk3lK9, on.pfizer.com/44fCXqO, and on.pfizer.com/3JEtDTT

Today kicks off #ACC24 where Pfizer is proud to be sharing our latest scientific research with the #ATTRCM community. on.pfizer.com/3TKWA6q #CardioX #ACC24 #PfizerMedical

Hear about recent research on a #TTRstabilizer and key disease markers such as 6MWT, KCCQ, and NT-pro-BNP levels in ATTR-CM! Click here to know more. on.pfizer.com/3xbdhiI #ATTRCM #CardioX #ACC24 #PfizerMedical

This week, in @JCC_IBD, data in patients with isolated #proctitis enrolled in the Phase 3 ELEVATE #UC clinical program with our once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator were published. #ulcerativecolitis #PfizerMedical

Join #PfizerMedical at the 2024 THSNA where we are sharing our latest hemophilia scientific research. #PfizerRareDisease on.pfizer.com/49A0aoN

Join #PfizerMedical at the 2024 THSNA where we are sharing our latest hemophilia scientific research. #PfizerRareDisease on.pfizer.com/3PGafJG

Join us at #ACC24 on Saturday, April 6th at 2:45 PM where we will share real-world effectiveness and safety outcomes among Medicare patients with non-valvular atrial fibrillation who switched between certain oral anticoagulants. #AtrialFibrillation #PfizerMedical

#PfizerMedical is pleased to be at the Thrombosis and Hemostatis Summit of North America (THSNA) sharing our latest #hemophilia scientific research. Visit us at Booth Number 104 #PfizerRareDisease on.pfizer.com/4aDEhpe

Dear Healthcare Providers – We invite you to explore key clinical trial data on an FDA-approved treatment for patients with severe #AlopeciaAreata. Click to learn more from an easy-to-understand infographic. #PfizerMedical #Dermatology

At Pfizer, we are committed to advancing the treatment of #Dermatomyositis. During #GCOM24, visit us at our booth to learn more about our scientific research. #PfizerMedical

Today kicks off #GCOM2024 where we will be sharing our latest scientific research with the #Dermatomyositis community. Come view our poster presentation to learn more about our latest data. #PfizerMedical

Pfizer is committed to advancing research in immuno-inflammatory diseases in #dermatology. If you haven’t stopped by already, visit us at booth #4319 at #AAD2024 to learn more. #PfizerMedical

Late breaking: Come hear new late-breaking data about an oral JAK3/TEC family kinase inhibitor today at #AAD2024, from Dr. Emma Guttman-Yasskey and Dr. Melissa Piliang. Follow the link to learn more. #PfizerMedical

Watch a short documentary, Day One, that follows the stories of three patients with #AlopeciaAreata (AA). This film will be followed by an expert-led discussion on shared decision making in AA. #AAD2024. Click to register. #PfizerMedical #dermatology

Pfizer is proud to be a part of the 2024 American Academy of Dermatology Annual Meeting #AAD2024. Learn more about our latest scientific research in #Dermatology. #PfizerMedical

We invite you to two expert-led dermatology programs in San Diego at #AAD2024 that explore the need for greater cultural competencies in treating diverse populations. Click to register and learn more. #PfizerMedical #AlopeciaAreata #AtopicDermatitis #Vitiligo

A real world evidence study published in the Journal of Clinical Medicine examined the potential impact of switching or continuing certain oral anticoagulants in patients with non-valvular atrial fibrillation. Read it at on.pfizer.com/3Ikz2yG. #nvaf #pfizermedical

#PfizerMedical invites you to learn more about data on the long-term efficacy and safety profile of an oral therapy for moderate-to-severe #AtopicDermatitis (AD) by viewing this interactive PDF. on.pfizer.com/40CtLLa

The #PfizerMedical Portal contains an infographic highlighting the Impact of COVID-19 on Mental Health Conditions.